SalmoneUla enteritidis 27655-3b and a few diarrheagenic Escherichia coli strains produce morphologically and antigenically related, thin, aggregative fimbriae, collectively named GVVPQ fimbriae (S. K. Collinson, L.
Presumptive positive and representative negative strains were examined by Western blotting (immunoblotting) by using antiserum to SEF 17, the native GVVPQ fimbria of S. enteritidis. Only four S. enteritidis strains and six E. coli isolates possessed substantial amounts of GVVPQ fimbriae after 24 h of incubation on T medium. Following 5 days of incubation, 56 of 93 SalmoneUla isolates (60%o) and 1 of 7 additional E. coli clinical isolates possessed detectable levels of GVVPQ fimbriae. Since variable expression of GVVPQ fimbriae was observed among SalmoneUla isolates and some E. coli strains produced scant amounts, as revealed by immunoelectron microscopy, the ability to produce these fimbriae was evaluated by genotypic screening. The Salmonellae are invasive enteropathogens of humans and animals (13) . Salmonellosis accounts for 2 million to 4 million cases of food-borne infection annually in the United States and contributes substantially to the estimated 1 billion annual cases of potentially fatal, food-borne diarrheal disease in children worldwide (7, 23) . The increase in salmonellosis in industrialized countries over the past 35 years has accompanied the centralization of food production and processing, despite improvements in epidemiological and microbiological methods. During the past decade, a dramatic increase in the occurrence of Salmonella enteritidis infections was principally responsible for the rise of food-borne salmonellosis in the United States and Europe (35) . Estimates of the economic costs of salmonellosis in the United States vary from $50 million to $23 billion annually, arising from lost productivity and medical treatment (7, 23, 46) , with comparable per-capita costs reported for other industrialized countries (41, 45 from the environment is practically impossible; therefore, the development of preventative and control measures are necessary, including improved diagnostics, vaccines, and hazard analysis (HACCP) education to limit the recurrence of disease.
Salmonella pathogenesis is poorly understood, but the molecular complexities are beginning to be appreciated (11, 12, 15, 19, 25, 26, 29) . The role of bacterial cell surface structures remains unresolved. Similar to other pathogenic bacteria, salmonellae produce surface appendages called fimbriae (or pili) that are composed of a single structural protein species, fimbrins, arranged helically in fibrils that are 2 to 7 nm in width (31) . Although certain types of Escherichia coli fimbriae are known to be important for virulence (21) , only type 1 fimbriae have been implicated in Salmonella pathogenicity (18, 22) .
S. enteritidis 27655-3b, a human isolate, produces three distinct fimbrial types, SEF 21 (type 1), SEF 17, and SEF 14 (9, 30) . SEF 17 fimbriae mediate fibronectin binding and bacterial autoaggregation (8) . SEF 17 are composed primarily of AgfA, a 17,000-molecular-weight (MW) fimbrin protein, and require depolymerization with 90% formic acid prior to analysis by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) (9) . Certain clinical isolates of diarrheagenic E. coli produce thin, aggregative 2264 DORAN ET AL. fimbriae composed of 18,000-MW fimbrins that are biochemically and serologically related to AgfA (10) . The AgfArelated E. coli HB101 fimbrin was named "curlin," the gene encoding it was designated csgA, and the corresponding thin, aggregative fimbriae were named "curli" by Normark and coworkers (3). The class of fimbriae which includes S. enteritidis SEF 17 and E. coli curli has been termed GVVPQ fimbriae by Collinson et al. (10) in recognition of common fimbrin N-terminal sequences.
The present study was initiated to determine the extent of the distribution of GVVPQ fimbriae among Salmonella serovars and other enteropathogenic members of the family Enterobactenaceae. Determination of the distributions of sequences homologous to the AgfA fimbrin gene, agfA, among isolates of Salmonella and other members of the family Enterobacteriaceae resulted in the development of novel DNA-based diagnostic tests for Salmonella spp.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The strains of Salmonella, other members of the family Enterobactenaceae, and eubacteria used in the present study and their sources are provided in Table 1 . Panels of Enterobacteriaceae arrayed on hydrophobic grid membrane filters (HGMFs; Gelman Sciences, Montreal, Quebec, Canada) were replicated (HGMF Replicator, Richard Brancker Research, Ottawa, Ontario, Canada) and were grown as described by Sharpe et al. (40) . To promote the production of GVVPQ fimbriae and to assay Congo red binding ability (8, 10) , the bacterial strains were grown on T medium. All bacteria except isolates of Serratia marcescens, Erwinia caratovora, Aeromonas salmonicida, and Aeromonas hydrophila were grown at 37°C; S. marcescens and E. caratovora were grown at 25°C, and A. salmonicida and A. hydrophila were grown at 20°C.
SDS-PAGE and Western blot analysis. SDS-PAGE and Western blot (immunoblot) analyses of putative GVVPQ fimbrins were conducted as described by Collinson et al. (8, 10) .
Electron microscopy. Bacteria were immunogold labeled with rabbit immune serum to SEF 17 and protein A-gold (Auroprobe; Pharmacia, Uppsala, Sweden), negatively stained, and observed with a Philips EM300 electron microscope operated at 60 kV (9) .
Amplification, cloning, and sequencing of agfA. A 394-bp agfA DNA fragment was amplified from S. enteritidis 27655-3b TnphoA mutant 2-7f by the polymerase chain reaction (PCR) as described previously (8) . To facilitate subcloning of the agfA PCR fragment, primers were constructed to introduce terminal restriction endonuclease cleavage sites. A 34-bp biased, oligonucleotide mixture,
, was designed from DNA sequences corresponding to amino acid residues 2 to 7 of the AgfA N terminus (9) and incorporated a hexanucleotide sequence (underlined) which is required to create an EcoRI cleavage site in the PCR product. The opposite-strand primer, TAF2 (dGGGAAAGGTTGAATTCAGGACGCTAC TTGTG), into which three nucleotide changes (underlined) were introduced to create an EcoRI site in the PCR product, was complementary to the IS50L sequence residing at the junction of TnphoA-generated alkaline phosphatase gene fusions (27) .
The amplified 394-bp agfA fragment was isolated by agarose (1.5%) gel electrophoresis in Tris-acetate-EDTA (37) or by the method of Alm et al. (1) . The DNA was quantified by spectroscopy, and 0.5-,g samples were applied to HyBond-N+ nylon membranes (Amersham Canada Inc., Oakville, Ontario, Canada) by using a dot blot manifold. A total of 546 Salmonella serovars, 239 other Enterobacteriaceae strains, and 22 isolates of other eubacteria were screened for agfArelated genes as colony blots prepared on HGMF panels as described previously (32) . The presence of Salmonella DNA on the HGMF panels was verified by hybridization with a mixture of total DNA prepared from S. entenitidis, S. typhimuium, and S. berta which was labeled with [a-32P] dATP by random primer-directed DNA synthesis (37) . An agfA gene probe was similarly constructed from the 394-bp agfA PCR fragment described above. DNA blots were prehybridized at 65°C in prehybridization buffer (37) (dCGGGCATCG[C/G]TITGCAGAGCAAGCGC), which was derived from the opposite-strand sequence corresponding to amino acid residues 36 to 44 (see Fig. 3 ). To favor amplification of a 92-bp fragment from both Salmonella and E. coli isolates, single-amino-acid differences in the corresponding regions of the AgfA and curlin fimbrins (see Fig. 4) were taken into consideration in the synthesis of TAF5 and TAF6 as mixtures of two oligonucleotides.
Bacterial DNA samples for PCR analyses were prepared from cells (20 Fig. 1 ).
Prolonged incubation also resulted in the expression by an additional E. coli clinical isolate of an 18,000-MW protein that was cross-reactive with AgfA and the production of a cross-reactive, 19,000-MW protein by a strain of E. aerogenes (Table 1 ; Fig. 1 ).
Variation in GVVPQ fimbrin production was evident within serovars of Salmonella as exemplified by 5 of 22 S. enteritidis isolates, 1 of 5 S. infantis isolates, 1 of 2 S. muenchen isolates, 4 of 5 S. pullorum isolates, and 6 of 12 S. typhimuinum isolates which did not produce detectable levels of AgfA (Table 1) . Similarly, there was evidence of variable expression of GVVPQ fimbriae among E. coli isolates, because 6 of 13 strains did not possess quantities of GVVPQ fimbrin detectable by Western blot analysis (Table  1) . Several E. coli strains considered to be nonproducers of GVVPQ fimbriae were examined by immunoelectron microscopy by using rabbit antiserum generated to the SEF 17 fimbriae of S. enteritidis. E. coli ATCC 11775, B41M, E1049a-13, and C600, which were grown at 37°C, infrequently possessed thin fimbriae decorated with anti-SEF 17 27655-3b . Aggregative fimbriae from colonies grown on T medium for 5 days were solubilized and subjected to Western blot analysis as described by Collinson et al. (8) . Anti-AgfA immune serum served as the primary antibody. Visualization of proteins that were immunologically cross-reactive with AgfA was accomplished by using goat, anti-rabbit, immunoglobulin G-alkaline phosphatase conjugates (Caltag Laboratories, San Francisco, Calif.), the substrate 5-bromo-4-chloro-3-indolyl phosphate, and the enhancer Nitro Blue Tetrazolium (Sigma Chemical Co., St. Louis, Mo.). The molecular weights (in thousands) of comigrating, prestained protein standards (Bethesda Research Laboratories are noted.
antibody-protein A-gold conjugates as well as much more numerous unlabeled fimbriae with different morphologies (Fig. 2 ).
Amplification and sequencing of an agfA DNA probe. Since GVVPQ fimbriae were widely distributed among Salmonella serovars and were common to several E. coli strains yet were produced in variable amounts, a GVVPQ fimbrin gene probe was considered to be a useful tool for determining the distribution of GVVPQ fimbriae. The S. enteritidis 27655-3b TnphoA insertion mutant, strain 2-7f, which produced an AgfA-PhoA fusion protein of approximately 70,000 MW (8), was selected for use in the isolation of an agfA DNA probe. A DNA fragment spanning the agfA gene from the sequence corresponding to the mRNA triplet encoding the second amino acid residue of the mature AgfA fimbrin to the downstream IS50L linker region flanking the agfA-TnphoA junction was amplified by PCR by using primers TAF1 and TAF2. The amplified 394-bp DNA fragment was repeatedly subcloned into pUC19 to generate the plasmids pAGF1, pAGF3, and pAGF4. DNA sequencing confirmed that the PCR fragment contained a 333-bp region originating from the S. enteritidis agfA gene (Fig. 3) . The N-terminal region of the translated DNA sequence of the single open reading frame corresponded precisely to amino acid residues 2 to 31, as determined by N-terminal sequencing of AgfA (Fig. 4) . The amino acid composition of the translated sequence had a similar high glycine content (16%), high combined alanine, serine, plus glycine content (37%), low basic amino acid content (4.5%), and nearly 30% asparagine plus aspartic acid content, consistent with the total amino acid analysis of native AgfA fimbrin (9) . Minimally, three-quarters of the SEF 17 fimbrin was represented in the 333-bp region of agfA, considering that AgfA has an apparent MW of 17,000, as estimated by SDS-PAGE.
Distribution of agfA and related fimbrin genes. The PCRamplified agfA gene fragment was hybridized to DNA from a total of 896 bacterial strains represented as colony blots assembled on HGMF panels or as DNA dot blots on nylon membranes ( and cloned into pUC19. The bases underlined in the agfA sequence are common to portions of the PCR primers TAF1 and TAF2, which were used in the amplification of this fragment. Below the agfA sequence is the translated amino acid sequence from residues 2 to 112. The amino acid residues following the junction between AgfA and the truncated PhoA peptide (27) 4 . Comparison of N-terminal amino acid sequences of AgfA from S. enteritidis 27655-3b and GVVPQ fimbrins from E. coli Viet G, NG7c, and Gambia 3 with the sequence of AgfA predicted by the agfA sequence (Fig. 3) . Amino acid residues shared by AgfA and E. coli GVVPQ fimbrins are boxed. a indicates translation of the agfA sequence.
VOL. 31, 1993 Viet G, NG7c, and Gambia 3 revealed significant sequence similarity (Fig. 4) (24) or the spontaneous deletion of genes encoding P fimbriae and P-related fimbriae by extraintestinal E. coli (17) .
The utilization of an agfA nucleotide probe in combination with automatable HGMF technology (40) provides a valuable new diagnostic format for Salmonella spp. In comparison with other Salmonella DNA probes (5, 6, 14, 16, 34, 43, 48) , the agfA probe demonstrated excellent inclusivity and exclusivity properties representative of the high degree of conservation of agfA among Salmonella serovars. Under appropriately stringent conditions, we detected no hybridization of a 333-bp region of agfA to the vast majority (81%) of non-Salmonella members of the family Enterobacteriaceae represented on the HGMF panels, including almost all strains of E. coli, Citrobacter, and Enterobacter and all strains of Shigella, Serratia, and Yersinia. The relatively negligible levels of hybridization to 9% of E. coli strains, two Citrobacter strains, and a single isolate of E. cloacae in no way interfered with recognition of strongly hybridizing Salmonella DNA. Therefore, this diagnostic format is very competitive with existing Salmonella DNA hybridization assays for use in the prevention of food-borne or waterborne infection. Although fimbrial gene probes have been developed for strain-or serovar-specific diagnosis for certain strains of enterotoxigenic E. coli (24) , some pyelonephritic E. coli isolates (39) , and Pseudomonas aeruginosa isolates obtained from patients with cystic fibrosis (42) , application of the agfA probe is the first instance in which a fimbrial gene probe has been used as a genus-specific diagnostic tool.
The agfA-based PCR assay is potentially sensitive to the presence of a single cell and might most effectively serve as a highly sensitive, inexpensive, and rapid (s24 h) means of screening for Salmonella spp. since the cells present in aquatic samples and processed foods are typically present in low numbers and are often viable but unculturable (2, 36) . Although the PCR assay is not quantitative, there is zero tolerance for Salmonella isolates in foodstuffs. However, there are serious concerns for the potential interference of food which could obviate application of the PCR assay described here.
The development of a diagnostic test based on anti-AgfA polyclonal antibodies is improbable given the lack of the requisite exclusivity and, as a result of variable phenotypic expression of GVVPQ fimbriae in Salmonella isolates, the inclusivity required of a diagnostic test. Whether GVVPQ fimbriae occur in all Salmonella strains during infection or whether levels of production correlate with virulence is not known. The relatively low proficiency of GVVPQ fimbriae production by many Salmonella strains obtained from existing culture collections reflected biased sampling and strain deposition resulting from the strongly autoaggregative nature of high-level GVVPQ fimbria producers. Indeed, abundant production of GVVPQ fimbriae may partially account for the frequent reporting of untypeable Salmonella isolates since autoaggregation could mask the serotype profile when using standard agglutination tests to identify flagellar or lipopolysaccharide 0 antigens.
Congo red binding, a property associated with enteroinvasive E. coli and virulent strains of Yersinia and Shigella (4, 33, 44, 47) and potentially indicative of porphyrin-binding ability (20) , is also associated with GWPQ fimbria production (8, 10) . However, the Congo red plate assay reliably detected only abundant producers of GVVPQ fimbriae within 24 h. Other evidence indicates that GVVPQ fimbriae are produced by members of several genera of the family Enterobacteriaceae. A 19,000-MW protein that is crossreactive with AgfA was purified from E. aerogenes by using the unique, rigorous protocol developed for the isolation of GVVPQ fimbriae (10) . Weak hybridization of the agfA probe to isolates of S. sonnei, E. cloacae, C. freundii, and a Citrobacter sp. were indicative of related GVVPQ fimbrin VOL. 31, 1993 on July 7, 2017 by guest http://jcm.asm.org/ genes. Further evidence of a GVVPQ fimbrin gene in S. sonnei was obtained by PCR amplification of a 92-bp fragment from S. sonnei and both Salmonella and E. coli strains by using DNA primers derived from agfA of S. enteritidis.
The lower efficiency of amplification of the 92-bp fragment from S. sonnei is consistent with the degree of sequence dissimilarity indicated by weak hybridization of the agfA probe. Similarly, the relatively inefficient PCR amplification of csgA fragments from E. coli by using primers derived from agfA and the weak level of hybridization of the agfA DNA probe to DNAs from several E. coli strains demonstrate that the csgA and agfA sequences are less conserved than the respective N-terminal protein sequences (Fig. 4) (3,   10) . The development of a PCR assay for the detection of related GVVPQ fimbrin genes provides a reliable, rapid technique for further screening of a broad cross-section of members of the family Enterobacteriaceae for the potential to produce GVVPQ fimbriae. In turn, this work will facilitate efforts to understand the structure and antigenic relationships of GVVPQ fimbriae and the potential roles of members of this class of thin, aggregative fimbriae in enterobacterial pathogenesis.
